Our Pricing

Your Complete Guide to How Mounjaro Works For Weight Loss

Published on: June 03, 2026

Understanding how Mounjaro works for weight loss UK is essential before starting treatment. Mounjaro (tirzepatide) is the first dual GIP/GLP-1 receptor agonist licensed by the MHRA, targeting two distinct hormonal pathways to reduce appetite, slow gastric emptying, and improve metabolic function. At Cured Pharmacy, we provide genuine UK-licensed Mounjaro from £124.99 with transparent pricing and expert clinical support from our UK-registered prescribers.

How Mounjaro Works: The Dual-Action Mechanism

Mounjaro contains tirzepatide, a novel medication that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously [1]. This dual-action mechanism distinguishes it from single-pathway treatments like semaglutide (Wegovy) or liraglutide (Saxenda), which target only GLP-1 receptors.

When you inject Mounjaro subcutaneously once weekly, tirzepatide binds to GIP and GLP-1 receptors in the pancreas, brain, and gastrointestinal tract [1]. GLP-1 activation reduces appetite through hypothalamic signalling, slows gastric emptying to prolong satiety, and enhances insulin secretion when blood glucose rises. GIP activation complements these effects by further improving insulin sensitivity and reducing glucagon secretion, creating a more comprehensive metabolic response [2].

In the SURPASS-2 trial comparing tirzepatide directly to semaglutide 1mg, patients receiving the highest tirzepatide dose (15mg) achieved an average body weight reduction of 12.4kg compared to 6.2kg with semaglutide over 40 weeks [3]. This superior efficacy is attributed to the synergistic effect of dual receptor activation, which clinical evidence suggests produces greater appetite suppression and metabolic improvement than GLP-1 agonism alone.

Clinical Evidence: Mounjaro Weight Loss Results in UK Trials

The SURPASS clinical trial programme evaluated tirzepatide's efficacy across multiple doses and patient populations. In SURPASS-3, participants receiving Mounjaro 15mg achieved an average 22.5% total body weight reduction over 72 weeks, with 63% of patients losing at least 20% of their initial body weight [1]. These results represent some of the most substantial weight reductions observed in any pharmacological obesity trial to date.

UK patients typically begin Mounjaro at a 2.5mg weekly dose, which is gradually increased every four weeks to minimise gastrointestinal side effects [4]. The maintenance dose ranges from 5mg to 15mg weekly, determined by your UK prescriber based on individual response and tolerability. Clinical trials demonstrate that higher doses correlate with greater weight loss, though the optimal dose varies between individuals.

Real-world UK data mirrors clinical trial findings, with patients commonly reporting significant appetite reduction within the first two weeks of treatment. However, it's essential to combine Mounjaro with a reduced-calorie diet and increased physical activity to optimise results, as the medication works synergistically with lifestyle modifications rather than replacing them [1][4].

Timeline of Expected Results

Most UK patients notice reduced appetite and early weight loss within 2-4 weeks of starting Mounjaro, though this varies individually. Clinically meaningful weight loss (≥5% body weight) typically occurs by week 12-16, with maximal effects observed after 52-72 weeks on a stable maintenance dose [1]. Your UK prescriber will monitor your progress through regular follow-up consultations to ensure safe, effective treatment continuation.

Mounjaro vs Wegovy: Comparing How They Work for Weight Loss

Both Mounjaro and Wegovy are injectable medications licensed by the MHRA for chronic weight management in the UK, but their mechanisms differ fundamentally. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that activates only one hormonal pathway, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 receptors for dual metabolic action [2][3].

Head-to-head trials demonstrate tirzepatide's superior efficacy. In SURPASS-2, patients on Mounjaro 15mg lost an average of 6.2kg more than those receiving semaglutide 1mg over 40 weeks [3]. The dual-receptor mechanism appears to produce greater appetite suppression and improved insulin sensitivity, translating to more substantial weight reduction in clinical practice.

However, treatment choice depends on individual factors beyond efficacy alone. Some UK patients experience better tolerability with semaglutide's single-pathway action, whilst others prefer tirzepatide's more potent effects despite potentially higher gastrointestinal side effects during dose escalation. Your UK prescriber will assess your medical history, previous treatment responses, and individual goals to recommend the most appropriate option.

Which Treatment Is Right for You?

At Cured Pharmacy, our UK-registered clinical team evaluates multiple factors when recommending weight loss treatments, including your BMI, comorbidities (such as type 2 diabetes or hypertension), previous medication trials, and budget considerations. Mounjaro may be particularly suitable if you require maximal weight reduction or have not achieved adequate results with single-pathway GLP-1 treatments. All prescription decisions require clinical assessment by a UK prescriber through our free online consultation, which takes under three minutes to complete.

How to Use Mounjaro: Dosing and Administration in the UK

Mounjaro arrives as a pre-filled KwikPen containing a single weekly dose. UK prescribers typically initiate treatment at 2.5mg weekly for four weeks, then increase to 5mg weekly for the next four weeks [4]. Further dose escalations to 7.5mg, 10mg, 12.5mg, or 15mg occur at four-week intervals based on individual response and tolerability, with the goal of reaching the lowest effective maintenance dose.

You'll inject Mounjaro subcutaneously into your abdomen, thigh, or upper arm once weekly, ideally on the same day each week. The injection takes seconds and uses a fine needle that most UK patients find comfortable. Rotate injection sites weekly to prevent lipohypertrophy (localised fat accumulation under the skin). If you miss a dose, administer it within four days; if more than four days have passed, skip the missed dose and resume your regular schedule [4].

Common side effects during dose escalation include nausea, diarrhoea, reduced appetite, vomiting, and constipation, which typically diminish as your body adjusts [1][4]. These gastrointestinal effects reflect Mounjaro's mechanism of action—slowed gastric emptying and altered gut hormone signalling. Starting at a low dose and escalating gradually minimises these effects whilst maintaining therapeutic efficacy. Your UK prescriber will provide specific guidance on managing side effects and adjusting your dose if needed.

Who Can Use Mounjaro for Weight Loss in the UK

The MHRA has licensed Mounjaro for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. UK prescribers assess eligibility through clinical consultation, reviewing your medical history, current medications, and contraindications before prescribing.

Mounjaro is contraindicated if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as tirzepatide may increase thyroid C-cell tumour risk based on rodent studies [4]. It's also unsuitable during pregnancy or breastfeeding, or if you have severe gastrointestinal disease such as inflammatory bowel disease or diabetic gastroparesis. Your UK prescriber will evaluate these factors during your free online consultation at Cured Pharmacy.

If you're currently taking other weight loss medications, insulin, or medications that slow gastric emptying, inform your prescriber, as dose adjustments or alternative treatments may be necessary. Mounjaro can be used alongside metformin, SGLT2 inhibitors, and most other common medications, but requires careful monitoring when combined with insulin or sulfonylureas due to hypoglycaemia risk [4].

Monitoring and Long-Term Use

UK prescribers typically review treatment response after 12-16 weeks. If you haven't achieved at least 5% body weight reduction by this point, your prescriber may recommend dose adjustment or alternative treatments [4]. Long-term Mounjaro use is safe in clinical trials extending beyond 72 weeks, though ongoing monitoring ensures continued efficacy and safety. At Cured Pharmacy, our clinical team provides regular follow-up consultations to support your weight loss journey and adjust treatment as needed.

Getting Mounjaro Online: How Cured Pharmacy Works

At Cured Pharmacy, accessing Mounjaro begins with a free online consultation that takes under three minutes. You'll answer questions about your medical history, current medications, weight loss goals, and any contraindications. Our UK-registered prescribers (overseen by Superintendent Pharmacist Tarun Kumar, GPhC 2233073) review your consultation within hours and determine if Mounjaro is clinically appropriate for you.

If approved, we dispense genuine UK-licensed Mounjaro from our GPhC-registered pharmacy (9012511) and arrange discreet next-day delivery across the UK. Our transparent upfront pricing means you'll see the exact cost—from £124.99 depending on your prescribed dose—before completing your consultation, with no hidden fees or surprise charges. We guarantee the lowest prices in the UK, ensuring cost never prevents you from accessing effective weight loss treatment.

All Mounjaro supplied by Cured Pharmacy is sourced through legitimate UK pharmaceutical channels and stored in temperature-controlled facilities to maintain medication integrity. We provide comprehensive patient information leaflets, injection technique guidance, and ongoing clinical support throughout your treatment. If you experience side effects or have questions, our UK clinical team is available via phone (+44 116 4646009) or online consultation for expert advice.

Why Choose Cured Pharmacy for Mounjaro

Cured Pharmacy combines clinical expertise, transparent pricing, and patient-centred service to deliver exceptional weight loss care. Unlike high-street pharmacies with limited stock and inflated prices, we maintain consistent Mounjaro availability at the UK's lowest guaranteed prices. Our fully remote service eliminates the need for GP appointments or in-person pharmacy visits, whilst our UK-registered clinical team ensures you receive the same expert assessment and ongoing monitoring as traditional healthcare settings. Start your free consultation today to discover if Mounjaro is right for your weight loss goals.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). https://www.medicines.org.uk/emc/product/14895 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including diet, exercise, and adherence to treatment. Mounjaro is a prescription-only medicine and may not be suitable for everyone.